阿司匹林和氯吡格雷抗血小板治疗高龄老年冠心病患者的临床研究
被引量:9
出处
《临床荟萃》
CAS
北大核心
2008年第20期1499-1501,共3页
Clinical Focus
基金
安徽省教育厅自然科学研究项目(2006KJ309B)
参考文献11
-
1Hennekens CH. Update on aspirin in the treatment and prevention of cardiovascular disease[J].Am J Managed Care, 2002,8(Suppl 22),S691-700.
-
2Chan FK,Ching JY, Hung LC,et al. Clopidogrel versus aspirin and esomeprezole to prevent recurrent ulcer bleeding[J]. N Eng J Med,2005,352(3):238-244.
-
3Patrono C, Coller B, FitzGerald GA, et al. Platelet-active drugs: the relationships among dose, effectiveness and side effects. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J]. Chest, 2004, 126 (3 Suppl):S234- 264.
-
4Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients[J]. BMJ, 2002,324(7329) : 71-86.
-
5李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
-
6Patrono C, Bachmann F, Baigent C, et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascualr disease of the european society of cardiology[J]. Eur Heart J,2004,25(2) :166-181.
-
7Geiger J, Brich J, Honig-Liedl P, et al. Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel[J]. Arterioscler Thromb Vasc Biol, 1999,19 (8):2007-2011.
-
8CAPRIE Steering Committee. A randomized, blinded, trial of elopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J]. Lancet, 1996,348 (9038) : 1329-1339.
-
9刘岩,郝卫军,司全金,李小鹰.高龄老年应用氯吡格雷与阿司匹林抗血小板治疗的临床研究[J].中华老年心脑血管病杂志,2006,8(4):219-221. 被引量:22
-
10Tarjan J, Salamon A, Jager R, et al. The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary diseases, previously undergoing secondary salicylic acid prophylaxis[J].Orv Hetil, 1999,140 (42):2339-2343.
二级参考文献19
-
1Patrono C,Bachmann F,Baigent C,et al.European Society of Cardiology.Expert consensus document on the use of antiplatelet agents.The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.Eur Heart J,2004,25:166-181.
-
2Eagle KA,Guyton RA,Davidoff R,et al.American College of Cardiology.American Heart Association Task Force on Practice Guidelines.American Society for Thoracic Surgery and the Society of Thoracic Surgeons.ACC/AHA 2004 guideline update for coronary artery bypass graft surgery:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).Circulation,2004,110:1168-1176.
-
3Stein PD,Alpert JS,Bussey HI,et al.Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.Chest,2001,119:2205-2275.
-
4Chen ZM,Jiang LX,Chen YP,et al.COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group.Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction:randomised placebo-controlled trial.Lancet,2005,366:1607-1621.
-
5Patrono C,Coller B,FitzGerald GA,et al.Platelet-active drugs:the relationships among dose,effectiveness,and side effects:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest,2004,126(3 Suppl):234S-264S.
-
6Pearson TA,Blair SN,Daniels SR,et al.AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke:2002 Update:Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases.American Heart Association Science Advisory and Coordinating Committee.Circulation,2002,106:388-391.
-
7Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304.
-
8Antithrombotic Trialists' Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
-
9Yusuf S,Zhao F,Mehta SR,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med,2001,345:494-502.
-
10Juul-Moller S,Edvardsson N,Jahnmatz B,et al.Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.Lancet,1992,340:1421-1425.
共引文献208
-
1付宁红.心血管内分泌学:内分泌医师面临的挑战[J].医学信息(医学与计算机应用),2014(27):585-585.
-
2陈明,王茜婷.经皮冠状动脉介入治疗抗血小板治疗现状和进展[J].中国医学前沿杂志(电子版),2011,3(3):43-49. 被引量:8
-
3赵冬琴.21例不稳定性心绞痛阿司匹林+氯吡格雷治疗疗效观察[J].中国临床实用医学,2007,1(7). 被引量:1
-
4李小鹰.在动脉硬化性心血管病防治中规范应用阿司匹林[J].中华心血管病杂志,2006,34(5):477-480. 被引量:22
-
5韩雅玲,王效增.不稳定型心绞痛和非ST段抬高心肌梗死的介入治疗[J].中国实用内科杂志,2006,26(8):1131-1133. 被引量:10
-
6吴兆苏.多重心血管病危险综合防治建议[J].中华心血管病杂志,2006,34(12):1061-1071. 被引量:120
-
7李宇华,李学军.剂量与药物治疗及药物发现的关系[J].医药导报,2007,26(1):1-5. 被引量:2
-
8孙卫东.阿司匹林在心血管病防治中的合理应用[J].中国社区医师,2007,23(2):15-16. 被引量:1
-
9崔忠太,邵秀芹,孙庆华,黄浩.某学院校医院门诊处方中不合理用药问题分析[J].中国校医,2007,21(1):42-43. 被引量:1
-
10阮淑萍.阿司匹林抵抗[J].浙江实用医学,2007,12(1):74-75.
同被引文献65
-
1赵秀丽,胡大一,李田昌,肖洁,边红.氯吡格雷对冠心病患者的安全性和血小板聚集率的影响[J].中国新药杂志,2004,13(10):933-935. 被引量:12
-
2王洁,杨凯平,汪茜,李小鹰.老年急性冠脉综合征与血浆纤维蛋白原、血小板集聚率的关系[J].中华急诊医学杂志,2005,14(8):629-632. 被引量:8
-
3王秋娟,吴锦慧,毛培江,平其能.前列地尔脂质体对血小板功能的影响及注射部位的刺激性的实验研究[J].中国新药与临床杂志,2006,25(1):29-32. 被引量:5
-
4李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
-
5刘岩,郝卫军,司全金,李小鹰.高龄老年应用氯吡格雷与阿司匹林抗血小板治疗的临床研究[J].中华老年心脑血管病杂志,2006,8(4):219-221. 被引量:22
-
6顾晴,陈纪林,陈曦.阿司匹林和氯吡格雷抑制兔粥样硬化主动脉基质金属蛋白酶1的表达[J].中国动脉硬化杂志,2006,14(7):577-580. 被引量:11
-
7李勇,唐捷.前列地尔的药理研究进展[J].西南军医,2006,8(6):79-81. 被引量:70
-
8施冰,姚依群,周书明.老年冠心病患者经皮冠状动脉介入术后联合应用阿司匹林和氯比格雷的安全性研究[J].中国临床保健杂志,2007,10(4):343-344. 被引量:13
-
9陈灏珠.心脏病学[M].5版.北京:人民卫生出版社,2001:1401-1419.
-
10池菊芳,郭航远,彭放,杨彪.经皮冠状动脉介入治疗术后长期联合阿司匹林和氯吡格雷抗血小板治疗的安全性评价[A].第12届中国南方国际心血管病学术会议专刊[C].2010,33(19):152-153.
引证文献9
-
1沙会然.阿司匹林及氯吡格雷对老年冠心病患者临床治疗比较[J].医学信息(医学与计算机应用),2014,0(20):438-439.
-
2程磊.氯吡格雷与阿司匹林治疗老年冠心病疗效对比研究[J].医学信息(医学与计算机应用),2014,0(12):426-426.
-
3王嫘,滕赞,梁冬科,陈思娇.前列地尔对老年冠状动脉粥样硬化性心脏病患者血小板聚集率的影响[J].现代预防医学,2011,38(6):1153-1154. 被引量:19
-
4沙艳梅.大于80岁高龄患者阿斯匹林安全性观察[J].心血管病防治知识(学术版),2013,3(3):18-19.
-
5黄荣华,马爱霞,李洪超.阿司匹林和氯吡格雷治疗老年冠心病疗效及安全性的Meta分析[J].中国药物评价,2013,30(2):100-106. 被引量:28
-
6姚慧娟,卜书红,沈艳琳,李平,张健.对一例2型糖尿病合并冠心病和心律失常患者的用药分析及药学监护[J].中国临床药学杂志,2014,23(1):51-55. 被引量:1
-
7潘凤珍.阿司匹林及氯吡格雷对老年冠心病患者临床治疗比较[J].中外医学研究,2014,12(26):33-34. 被引量:3
-
8张春红.氯吡格雷与阿司匹林治疗老年冠心病的疗效评价[J].中国医药指南,2015,13(2):187-188. 被引量:7
-
9王强,李子玲,徐平,何永桂.氯吡格雷治疗稳定型冠心病的疗效观察[J].中国医院用药评价与分析,2016,16(2):151-153. 被引量:12
二级引证文献70
-
1方志成,周昌娥,郑翔,杨宝义,刘伯毅,陈黎,黄云飞.前列地尔治疗急性冠脉综合征心肌损伤作用的临床研究[J].心血管康复医学杂志,2012,21(6):626-629. 被引量:8
-
2怯红晓,邵芳,于维雅.前列地尔在老年不稳定型心绞痛患者中的疗效观察[J].中国现代医药杂志,2013,15(7):74-75. 被引量:3
-
3周海立,郝钟兰.前列地尔联合氟伐他汀治疗急性冠脉综合征的疗效观察[J].贵阳中医学院学报,2014,36(2):21-23. 被引量:1
-
4万巧英.前列地尔对急性冠状动脉综合征患者血清H-FABP和MMP-9的影响[J].中国实用医刊,2014,41(16):44-46.
-
5郭建华,杨雅娟.氯吡格雷与阿司匹林治疗老年冠心病的临床疗效[J].检验医学与临床,2014,11(16):2289-2290. 被引量:21
-
6张春红.氯吡格雷与阿司匹林治疗老年冠心病的疗效评价[J].中国医药指南,2015,13(2):187-188. 被引量:7
-
7颜程光,王俊谊,黄贵奇,陈添华.氯吡格雷对PCI患者血小板功能状态及血流变的影响[J].心血管康复医学杂志,2014,23(6):671-674. 被引量:5
-
8吴立峰.前列地尔治疗不稳定型心绞痛疗效观察[J].中国现代药物应用,2015,9(6):109-110. 被引量:3
-
9欧冬静.阿司匹林和氯吡格雷治疗老年冠心病疗效及安全性[J].中国卫生产业,2014,11(18):90-91. 被引量:7
-
10张任,李正东.肾康注射液联合西医治疗慢性肾衰竭疗效及对脂代谢紊乱的影响[J].医学综述,2015,21(7):1322-1324. 被引量:14
-
1苏温兰.无创呼吸机治疗慢性阻塞性肺疾病合并呼吸衰竭42例患者的护理[J].重庆医学,2010,39(11):1468-1469. 被引量:67
-
2谢冬梅,尹寒麒,张晓艳.心肌梗塞和脑梗塞溶栓治疗的循证医学证据[J].西藏医药,2002,23(1):11-13.
-
3高洁,盖萍,沙晶,陈良华,朱兴雷.冠状动脉狭窄程度与高敏C反应蛋白的相关性研究[J].山东医药,2006,46(28):11-11. 被引量:4
-
4周长华,庄延兵,居建忻.血液透析患者血清白蛋白水平与心血管疾病的关系[J].浙江临床医学,2005,7(6):637-638. 被引量:6
-
5吕荣华.胰岛素为何要早用[J].医食参考,2013(2):24-24.
-
6郭立新.二甲双胍在糖尿病治疗中的地位和作用[J].药品评价,2010(15):40-44.
-
7程凤英,付春生,张桂菊.746例慢性乙型肝炎患者抗病毒治疗效果分析[J].山东医药,2007,47(11):68-69.
-
8肖文良,Jan Kovac.药物涂层支架在冠状动脉介入治疗中的地位和作用[J].临床心血管病杂志,2005,21(2):126-128. 被引量:5
-
9马虹,彭龙云.钙离子拮抗剂降压以外的作用[J].中国处方药,2007,6(2):55-58. 被引量:4
-
10杨兆民.试论健康教育在寄生虫病防治中的地位和作用[J].中国初级卫生保健,1993,7(2):41-42. 被引量:1